The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.

Lyric Semiconductor thinks it is probably time to blend analog and digital technology into a new technology they call probability processing. Analog values called pbits that are processed by ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Thomas J Catalano is a CFP and Registered ...

In a previous paper [3], the authors presented large sample optimum accelerated test plans to estimate the survival probability at a design stress assuming a linear logistic model, i. e. a linear ...